Orthopaedic Surgery,
Journal Year:
2024,
Volume and Issue:
16(3), P. 733 - 744
Published: Feb. 21, 2024
Objective
Glucocorticoid
(GC)
overuse
is
strongly
associated
with
steroid‐induced
osteonecrosis
of
the
femoral
head
(SINFH).
However,
underlying
mechanism
SINFH
remains
unclear.
This
study
aims
to
investigate
effect
dexamethasone
(Dex)‐induced
oxidative
stress
on
osteocyte
apoptosis
and
mechanisms.
Methods
Ten
patients
10
developmental
dysplasia
hips
(DDH)
were
enrolled
in
our
study.
Sixty
rats
randomly
assigned
Control,
Dex,
Dex
+
N‐Acetyl‐L‐cysteine
(NAC),
Dibenziodolium
chloride
(DPI),
NAC,
DPI
groups.
Magnetic
resonance
imaging
(MRI)
was
used
examine
edema
rats.
Histopathological
staining
performed
assess
osteonecrosis.
Immunofluorescence
TUNEL
8‐OHdG
conducted
evaluate
damage.
Immunohistochemical
carried
out
detect
expression
NOX1,
NOX2,
NOX4.
Viability
MLO‐Y4
cells
measured
using
CCK‐8
assay
staining.
stress.
2′,7′‐Dichlorodihydrofluorescein
diacetate
(DCFH‐DA)
measure
reactive
oxygen
species
(ROS).
The
NOX4
analyzed
by
Western
blotting.
Multiple
comparisons
one‐way
analysis
variance
(ANOVA).
Results
In
rat
model,
hematoxylin–eosin
(HE)
revealed
a
significantly
higher
rate
empty
lacunae
group
than
DDH
group.
indicated
significant
increase
TUNEL‐positive
8‐OHdG‐positive
compared
demonstrated
proteins
patients.
Moreover,
immunohistochemical
showed
proportion
NOX2‐positive
Control
vitro,
inhibited
viability
induced
apoptosis.
After
treatment,
intracellular
ROS
level
increased.
treatment
did
not
alter
NOX
vitro.
Additionally,
NAC
generation
partially
alleviated
vivo
Conclusion
demonstrates
that
GC
promotes
through
ROS‐induced
Furthermore,
we
found
increased
NOXs
serves
as
an
important
source
generation.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(4), P. 3772 - 3772
Published: Feb. 14, 2023
Osteoporosis
is
characterized
by
the
alteration
of
bone
homeostasis
due
to
an
imbalance
between
osteoclastic
resorption
and
osteoblastic
formation.
Estrogen
deficiency
causes
loss
postmenopausal
osteoporosis,
pathogenesis
which
also
involves
oxidative
stress,
inflammatory
processes,
dysregulation
expression
microRNAs
(miRNAs)
that
control
gene
at
post-transcriptional
levels.
Oxidative
increase
in
reactive
oxygen
species
(ROS),
proinflammatory
mediators
altered
levels
miRNAs
enhance
osteoclastogenesis
reduce
osteoblastogenesis
through
mechanisms
involving
activation
MAPK
transcription
factors.
The
present
review
summarizes
principal
molecular
involved
role
ROS
cytokines
on
osteoporosis.
Moreover,
it
highlights
interplay
among
miRNA
levels,
state.
In
fact,
ROS,
activating
transcriptional
factors,
can
affect
expression,
regulate
production
processes.
Therefore,
should
help
identifying
targets
for
development
new
therapeutic
approaches
osteoporotic
treatment
improve
quality
life
patients.
Experimental & Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
54(8), P. 1067 - 1075
Published: Aug. 17, 2022
Intervertebral
disc
degeneration
(IDD)
is
a
common
degenerative
musculoskeletal
disorder
and
recognized
as
major
contributor
to
discogenic
lower
back
pain.
However,
the
molecular
mechanisms
underlying
IDD
remain
unclear,
therapeutic
strategies
for
are
currently
limited.
Oxidative
stress
plays
pivotal
roles
in
pathogenesis
progression
of
many
age-related
diseases
humans,
including
IDD.
Nuclear
factor
E2-related
2
(Nrf2)
master
antioxidant
transcription
that
protects
cells
against
oxidative
damage.
Nrf2
negatively
modulated
by
Kelch-like
ECH-associated
protein
1
(Keap1)
exerts
important
effects
on
progression.
Accumulating
evidence
has
revealed
can
facilitate
downstream
genes
binding
response
elements
(AREs)
promoter
regions,
heme
oxygenase-1
(HO-1),
glutathione
(GSH),
superoxide
dismutase
(SOD),
catalase
(CAT),
NADPH
quinone
dehydrogenase
(NQO1).
The
defense
system
regulates
cell
apoptosis,
senescence,
extracellular
matrix
(ECM)
metabolism,
inflammatory
nucleus
pulposus
(NP),
calcification
cartilaginous
endplates
(EP)
In
this
review,
we
aim
discuss
current
knowledge
systematically.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(2), P. 373 - 373
Published: Feb. 3, 2023
This
review
reports
in
detail
the
cellular
and
molecular
mechanisms
which
regulate
bone
remodeling
process
relation
to
oxidative
stress
(OS),
inflammatory
factors,
estrogen
deficiency.
OS
is
considered
an
important
pathogenic
factor
of
osteoporosis,
inducing
osteocyte
apoptosis
varying
levels
specific
such
as
receptor
activator
κB
ligand
(RANKL),
sclerostin,
and,
according
recent
evidence,
fibroblast
growth
23,
with
consequent
impairment
high
resorption.
Bone
loss
increases
risk
fragility
fractures,
most
commonly
used
treatments
are
antiresorptive
drugs,
followed
by
anabolic
drugs
or
those
a
double
effect.
In
addition,
data
show
that
natural
antioxidants
contained
diet
efficient
preventing
reducing
negative
effects
on
osteocytes
through
involvement
sirtuin
type
1
enzyme.
Indeed,
some
their
factors
potential
biological
targets
can
act
prevent
reduce
loss,
well
promote
regenerative
processes
restoring
physiological
remodeling.
Several
suggest
including
novel
therapeutic
approaches
develop
better
management
strategies
for
prevention
treatment
osteoporosis
OS-related
diseases.
particular,
anthocyanins,
resveratrol,
lycopene,
oleuropein,
vitamins,
thiol
antioxidants,
could
have
protective
anti-osteoporotic
effects.
Frontiers in Molecular Biosciences,
Journal Year:
2022,
Volume and Issue:
9
Published: Sept. 20, 2022
Knee
osteoarthritis
(KOA)
is
one
of
the
most
common
degenerative
diseases,
and
its
core
feature
degeneration
damage
articular
cartilage.
The
cartilage
KOA
due
to
destruction
dynamic
balance
caused
by
activation
chondrocytes
various
factors,
with
oxidative
stress
playing
an
important
role
in
pathogenesis
KOA.
overproduction
reactive
oxygen
species
(ROS)
a
result
stress,
which
redox
process
that
goes
awry
inherent
antioxidant
defence
system
human
body.
Superoxide
dismutase
(SOD)
inside
outside
plays
key
regulating
ROS
Additionally,
synovitis
factor
development
In
inflammatory
environment,
hypoxia
synovial
cells
leads
mitochondrial
damage,
increase
levels,
further
aggravates
synovitis.
addition,
significantly
accelerates
telomere
shortening
ageing
chondrocytes,
while
promotes
KOA,
damages
regulation
mitochondria
cartilage,
stimulates
production
aggravate
At
present,
there
are
many
drugs
regulate
level
ROS,
but
these
still
need
be
developed
verified
animal
models
We
discuss
mainly
how
part
Although
current
research
has
achieved
some
results,
more
needed.
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
128, P. 155516 - 155516
Published: March 16, 2024
Recently,
osteoblast
pyroptosis
has
been
proposed
as
a
potential
pathogenic
mechanism
underlying
osteoporosis,
although
this
remains
to
be
confirmed.
Luteolin
(Lut),
flavonoid
phytochemical,
plays
critical
role
in
the
anti-osteoporosis
effects
of
many
traditional
Chinese
medicine
prescriptions.
However,
its
protective
impact
on
osteoblasts
postmenopausal
osteoporosis
(PMOP)
not
elucidated.
This
research
aimed
determine
effect
Lut
ameliorating
PMOP
by
alleviating
and
sustaining
osteogenesis.
was
designed
investigate
novel
both
cell
animal
models.
Ovariectomy-induced
models
were
established
mice
with/without
daily
gavaged
10
or
20
mg/kg
body
weight
Lut.
The
bone
microstructure,
metabolism
oxidative
stress
evaluated
with
0.104
Estradiol
Valerate
Tablets
positive
control.
Network
pharmacological
analysis
molecular
docking
employed
mechanisms
treatment.
Subsequently,
impacts
PI3K/AKT
axis,
stress,
mitochondria,
assessed.
In
vitro,
cultured
(MC3T3-E1(14)
cells
exposed
H2O2
examine
signaling
pathway,
osteogenic
differentiation,
mitochondrial
function,
pyroptosis.
Our
findings
demonstrated
that
Lut,
similar
control
drug,
effectively
reduced
systemic
loss
enhanced
induced
ovariectomy.
indicated
axis
target,
response
nuclear
membrane
function
being
key
mechanisms.
Consequently,
investigated.
vivo
data
revealed
deactivated
following
ovariectomy,
restored
phosphorylation
proteins,
thereby
reactivating
axis.
Additionally,
alleviated
abnormalities
intervention
mitigated
inhibition
osteogenesis,
well
H2O2-induced
Furthermore,
attenuated
ROS
accumulation
dysfunction.
including
osteogenesis
restoration,
anti-pyroptosis,
maintenance,
all
reversed
LY294002
(a
pathway
inhibitor).
summary,
could
improve
dysfunction,
alleviate
GSDME-mediated
maintain
via
activating
PI3K/Akt
offering
new
therapeutic
strategy
for
PMOP.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(1), P. 15 - 15
Published: Jan. 3, 2025
The
influence
of
serum
uric
acid
(SUA)
on
bone
metabolism,
as
suggested
by
previous
studies,
remains
a
contentious
issue.
SUA
plays
complex
role
in
health
and
hypertension,
making
it
challenging
to
discern
its
impact
the
skeletal
status
middle-aged
elderly
hypertensive
patients.
This
study
aims
elucidate
effects
health,
with
particular
focus
association
osteoporosis
risk
fractures.
Multiple
linear
regression
analyzed
levels
against
mineral
density
(BMD)
future
fracture
risk.
Additionally,
multivariate
logistic
was
used
examine
between
osteoporosis.
Dose-response
relationship
analysis
conducted
using
generalized
smooth
curve
fitting
(GSCF)
restricted
cubic
spline
(RCS)
methods.
With
exception
total
femur
region,
BMD
showed
positive
connection.
GSCF
revealed
an
inverted
U-shaped
BMD,
alongside
trend
FRAX
scores.
Moreover,
RCS
indicated
levels,
higher
risks
identified
first
third
tertiles
compared
second
tertile.
In
individuals
older
is
substantially
linked
health.
identification
relationships
scores
highlights
nuanced
SUA.
These
findings
suggest
that
both
low
high
may
adversely
affect
emphasizing
need
for
further
research.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 4, 2025
Osteoporosis
results
from
a
disruption
in
skeletal
homeostasis
caused
by
an
imbalance
between
bone
resorption
and
formation.
Conventional
treatments,
such
as
pharmaceutical
drugs
hormone
replacement
therapy,
often
yield
suboptimal
are
frequently
associated
with
side
effects.
Recently,
biomaterial-based
approaches
have
gained
attention
promising
alternatives
for
managing
osteoporosis.
This
review
summarizes
the
current
advancements
3D-printed
biomaterials
designed
osteoporosis
treatment.
The
benefits
of
compared
to
traditional
systemic
drug
therapies
discussed.
These
materials
can
be
broadly
categorized
based
on
their
functionalities,
including
promoting
osteogenesis,
reducing
inflammation,
exhibiting
antioxidant
properties,
inhibiting
osteoclast
activity.
3D
printing
has
advantages
speed,
precision,
personalization,
etc.
It
is
able
satisfy
requirements
irregular
geometry,
differentiated
composition,
multilayered
structure
articular
osteochondral
scaffolds
boundary
layer
structure.
limitations
existing
critically
analyzed
future
directions
considered.
Nanoscale,
Journal Year:
2023,
Volume and Issue:
15(31), P. 12818 - 12839
Published: Jan. 1, 2023
Prussian
Blue
Nanozymes
(PBNZs)
have
emerged
as
highly
efficient
agents
for
reactive
oxygen
species
(ROS)
elimination,
owing
to
their
multiple
enzyme-like
properties
encompassing
catalase
(CAT),
peroxidase
(POD),
and
superoxide
dismutase
(SOD)
activities.
As
a
functional
nanomaterial
mimicking
enzyme,
PBNZs
not
only
surmount
the
limitations
of
natural
enzymes,
such
instability
high
manufacturing
costs,
but
also
exhibit
superior
stability,
tunable
activity,
low
storage
expenses,
remarkable
reusability.
Consequently,
gained
significant
attention
in
diverse
biomedical
applications,
including
disease
diagnosis
therapy.
Over
past
decade,
propelled
by
advancements
catalysis
science,
biotechnology,
computational
nanotechnology,
witnessed
progress
exploration
enzymatic
activities,
elucidation
catalytic
mechanisms,
wide-ranging
applications.
This
comprehensive
review
aims
provide
systematic
overview
discovery
mechanisms
PBNZ,
along
with
strategies
employed
modulate
Furthermore,
we
extensively
survey
recent
utilizing
scavenging
ROS
various
Lastly,
analyze
existing
challenges
translating
into
therapeutic
clinical
use
outline
future
research
directions
this
field.
By
presenting
synopsis
current
state
knowledge,
seeks
contribute
deeper
understanding
immense
potential
an
innovative
agent
biomedicine.